Skip to main content
. 2016 Apr 11;7(29):46668–46677. doi: 10.18632/oncotarget.8694

Table 2. Biomarkers to predict response to anti-VEGF inhibitors.

Functional imaging
Hypertension
Circulating proteins (baseline plasma VEGF concentration and soluble VEGFR-2)
Circulating endothelial or tumor cells
Single nucleotide polymorphisms (SNPs)
Tumor biomarkers (CD31-positive tumor vessels; Tumor neuropilin 1 immunoreactivity; plasma levels of intercellular adhesion molecule-1)